HowShorted

How shorted is C4 Therapeutics, Inc.?

More shorted than 98% of the 2,877 ranked US companies

24.73%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+3.19
5 reports (~10 weeks)
+5.51
Aggregate net short position time series for C4 Therapeutics, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202624.73%+3.19
15 Jul 202621.54%−1.07
30 Jun 202622.61%+2.49
15 Jun 202620.12%+0.54
29 May 202619.58%+0.36
15 May 202619.22%−2.51
30 Apr 202621.73%+0.02
15 Apr 202621.71%+5.04
31 Mar 202616.67%+2.70
13 Mar 202613.97%+5.18
27 Feb 20268.79%+1.44
13 Feb 20267.35%−0.09
30 Jan 20267.44%−0.17
15 Jan 20267.61%+0.10
31 Dec 20257.51%+0.11
15 Dec 20257.40%+1.63
28 Nov 20255.77%+0.77
14 Nov 20255.00%+0.04
31 Oct 20254.96%−0.64
15 Oct 20255.60%+0.65
30 Sep 20254.95%−0.03
15 Sep 20254.98%−0.33
29 Aug 20255.31%−0.51
15 Aug 20255.82%−0.72
31 Jul 20256.54%–

Frequently asked questions

How shorted is C4 Therapeutics, Inc. right now?
24.73% of C4 Therapeutics, Inc.'s (CCCC) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.